Yanli Qu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 14
- Lung Cancer Research Studies 7
- Inflammatory Biomarkers in Disease Prognosis 3
- Co-authors
- Baogui Xin (1 shared paper)Xianbo Yu (1 shared paper)Haifeng Wang (1 shared paper)Kun Liu (1 shared paper)Zhenqiang Sun (1 shared paper)Yong Tang (1 shared paper)Yong Tang (4 shared papers)Hong Yu (7 shared papers)
- Journals
- International Journal of Surgery (3 papers)Biomarkers in Medicine (3 papers)Annals of Oncology (2 papers)Annals of Palliative Medicine (1 paper)Lipids in Health and Disease (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yanli Qu
24 papers receiving 300 citations
Peers
Comparison fields: 5 of 94
- Cancer Research 78
- Oncology 89
- Media Technology 18
- Transportation 13
- Otorhinolaryngology 8
Countries citing papers authored by Yanli Qu
This map shows the geographic impact of Yanli Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Qu more than expected).
Fields of papers citing papers by Yanli Qu
This network shows the impact of papers produced by Yanli Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Qu. The network helps show where Yanli Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanli Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma. | 2015 | 69 |
| 2 | 2019 | 59 | |
| 3 | 2016 | 34 | |
| 4 | 2024 | 28 | |
| 5 | 2015 | 14 | |
| 6 | 2021 | 14 | |
| 7 | 2015 | 10 | |
| 8 | 2019 | 9 | |
| 9 | 2024 | 8 | |
| 10 | 2017 | 7 | |
| 11 | 2014 | 7 | |
| 12 | 2020 | 7 | |
| 13 | 2021 | 6 | |
| 14 | 2024 | 6 | |
| 15 | 2015 | 6 | |
| 16 | 2023 | 3 | |
| 17 | 2021 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 2019 | 2 |
About Yanli Qu
Yanli Qu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 27 papers that have together received 301 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (7 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Lung Cancer Treatments and Mutations (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Esophageal Cancer Research and Treatment (3 papers), Genetic factors in colorectal cancer (2 papers), Economic and Financial Impacts of Cancer (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (78 citations), Oncology (89 citations), Media Technology (18 citations), Transportation (13 citations) and Otorhinolaryngology (8 citations). Yanli Qu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Baogui Xin, Xianbo Yu, Haifeng Wang, Kun Liu, Zhenqiang Sun, Yong Tang, Yong Tang, Hong Yu, Ning Zhou and Chunlei Xu. Their work appears in journals such as International Journal of Surgery, Biomarkers in Medicine, Annals of Oncology, Annals of Palliative Medicine and Lipids in Health and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.